Emergency Medicine Experts & Viewpoints
- Why Should I Report an Adverse Drug Event?
- Are Osteoporosis Risks Being Overlooked?
- What Is My Legal Obligation if I Allow an Intoxicated Patient to Drive Home?
- When Is it Appropriate to Use Methotrexate for Ectopic Pregnancy in the Emergency Department?
- Can Pharmacists Improve the Accuracy of Medication Histories?
- When Your Patients and In-laws Ask Whether They Should Receive the Shingles Vaccine
- What's the Impact of Air Bags After Trauma?
- The Association Between Secondary Hyperparathyroidism and Mortality in Men With Moderate to Severe Chronic Kidney Disease
- Is Penicillin Safe in a Patient Allergic to Cephalosporins?
- Retooling for an Aging America
POLL
A new bill in Congress would send trained clinicians into doctors’ offices with independent data about the relative benefits, risks, and costs of drugs; some research suggests that such "academic detailing" reduces potential prescribing bias from the influence of drug company reps. What effect do you think such a program would have?